Labroots

Optimizing Time-to-Detection in Bloodstream Infections: Insights from a Real-World Evaluation of Modified BD BACTEC™ Media

Bloodstream infections (BSIs) remain a critical challenge in clinical care, where every hour of delay in diagnosis can ...
Frontiers

Immune biomarkers in circulating cells of NSCLC patients can effectively evaluate the efficacy of chemotherapy combined with anti-PD-1 therapy

Introduction: The application of programmed cell death protein 1 (PD-1) antibodies has brought significant benefits to patients with non-small cell lung cancer (NSCLC). However, not all patients ...
eLife

Targeting Ribosome Biogenesis as a Novel Therapeutic Approach to Overcome EMT-related Chemoresistance in Breast Cancer

This study presents a valuable finding that pathways associated with ribosome biogenesis (RiBi) are activated during transition cell states and targeting ribosome biogenesis could be a viable approach ...
Frontiers

Antagonism of regulatory ISGs enhances the anti-melanoma efficacy of STING agonists

Background: Stimulator of Interferon Genes (STING) is a dsDNA sensor that triggers type I inflammatory responses. Recent data from our group and others support the therapeutic efficacy of STING ...
BioSpace

BD Biosciences launches BD FACSAria(TM) III Flow Cytometry System

Oxford, UK (9 March 2010) - BD Biosciences, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), announced today the launch of the BD FACSAria™ III Cell Sorting System, a next-generation flow ...